10-Q Filing

GUARDANT HEALTH, INC. CIK: 1576280 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001628280-19-013718`
Period End Date	20190930
Filing Date	20191107
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	gh-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 84 Cash Flow Statement 94 Stockholders Equity 60 Comprehensive Income 36

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	93.85M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$140.54M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	85.83M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$147.19M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	85.83M	shares	Point-in-time
Short-term marketable securities	`MarketableSecuritiesCurrent`	$278.42M	USD	Point-in-time
Short-term marketable securities	`MarketableSecuritiesCurrent`	$375.77M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	93.85M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$39.69M	USD	Point-in-time
Variable interest entity, assets	`VariableInterestEntityConsolidatedCarryingAmountAssets`	$45.10M	USD	Point-in-time
Variable interest entity, assets	`VariableInterestEntityConsolidatedCarryingAmountAssets`	$48.30M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$35.69M	USD	Point-in-time
Inventory	`InventoryNet`	$9.14M	USD	Point-in-time
Variable interest entity, liabilities	`VariableInterestEntityConsolidatedCarryingAmountLiabilities`	$1.20M	USD	Point-in-time
Variable interest entity, liabilities	`VariableInterestEntityConsolidatedCarryingAmountLiabilities`	$3.00M	USD	Point-in-time
Inventory	`InventoryNet`	$14.76M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.20M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.66M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$468.99M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$583.06M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$77.56M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$302.62M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$40.76M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$31.00M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$8.76M	USD	Point-in-time
Goodwill	`Goodwill`	$2.93M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Capitalized license fees	`FiniteLivedIntangibleAssetsNet`	$7.13M	USD	Point-in-time
Capitalized license fees	`FiniteLivedIntangibleAssetsNet`	$7.80M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.07M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.05M	USD	Point-in-time
Total Assets	`Assets`	$587.40M	USD	Point-in-time
Total Assets	`Assets`	$948.33M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.64M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.05M	USD	Point-in-time
Accrued compensation	`DeferredCompensationLiabilityCurrent`	$12.99M	USD	Point-in-time
Accrued compensation	`DeferredCompensationLiabilityCurrent`	$24.60M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$17.24M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.08M	USD	Point-in-time
Capital lease, current	`CapitalLeaseObligationsCurrent`	$80.00K	USD	Point-in-time
Capital lease, current	`CapitalLeaseObligationsCurrent`	$97.00K	USD	Point-in-time
Deferred rent, current	`DeferredRentCreditCurrent`	$745.00K	USD	Point-in-time
Deferred rent, current	`DeferredRentCreditCurrent`	-	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$16.14M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$13.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$46.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$67.82M	USD	Point-in-time
Capital lease, net of current portion	`CapitalLeaseObligationsNoncurrent`	$57.00K	USD	Point-in-time
Capital lease, net of current portion	`CapitalLeaseObligationsNoncurrent`	$119.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$7.84M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$10.56M	USD	Point-in-time
Obligation related to royalty	`AccruedRoyaltiesNoncurrent`	$7.34M	USD	Point-in-time
Obligation related to royalty	`AccruedRoyaltiesNoncurrent`	$6.78M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$206.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.22M	USD	Point-in-time
Total Liabilities	`Liabilities`	$62.45M	USD	Point-in-time
Total Liabilities	`Liabilities`	$86.44M	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$46.50M	USD	Point-in-time
Redeemable noncontrolling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$41.80M	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of September 30, 2019 and December 31, 2018; 93,853,390 and 85,832,454 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of September 30, 2019 and December 31, 2018; 93,853,390 and 85,832,454 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.14B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$764.03M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-83.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-280.80M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-327.60M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$483.15M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$255.19M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$276.78M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$308.61M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$468.13M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$815.40M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$296.85M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$815.47M	USD	Point-in-time
Total Liabilities, Redeemable Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$587.40M	USD	Point-in-time
Total Liabilities, Redeemable Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$948.33M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Precision oncology testing	`RevenuefromPrecisionOncologyTesting`	$123.05M	USD	3 Qtrs
Precision oncology testing	`RevenuefromPrecisionOncologyTesting`	$52.15M	USD	1 Quarter
Precision oncology testing	`RevenuefromPrecisionOncologyTesting`	$18.30M	USD	1 Quarter
Precision oncology testing	`RevenuefromPrecisionOncologyTesting`	$50.31M	USD	3 Qtrs
Development services	`RevenuefromDevelopmentServices`	$8.70M	USD	1 Quarter
Development services	`RevenuefromDevelopmentServices`	$28.43M	USD	3 Qtrs
Development services	`RevenuefromDevelopmentServices`	$3.39M	USD	1 Quarter
Development services	`RevenuefromDevelopmentServices`	$7.46M	USD	3 Qtrs
Total revenue	`Revenues`	$57.77M	USD	3 Qtrs
Total revenue	`Revenues`	$21.69M	USD	1 Quarter
Total revenue	`Revenues`	$151.48M	USD	3 Qtrs
Total revenue	`Revenues`	$60.85M	USD	1 Quarter
Cost of precision oncology testing	`CostsofPrecisionOncologyTesting`	$9.67M	USD	1 Quarter
Cost of precision oncology testing	`CostsofPrecisionOncologyTesting`	$42.25M	USD	3 Qtrs
Cost of precision oncology testing	`CostsofPrecisionOncologyTesting`	$16.58M	USD	1 Quarter
Cost of precision oncology testing	`CostsofPrecisionOncologyTesting`	$27.22M	USD	3 Qtrs
Cost of development services	`CostofDevelopmentServices`	$380.00K	USD	1 Quarter
Cost of development services	`CostofDevelopmentServices`	$1.94M	USD	1 Quarter
Cost of development services	`CostofDevelopmentServices`	$2.04M	USD	3 Qtrs
Cost of development services	`CostofDevelopmentServices`	$6.63M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$60.42M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$24.57M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$34.06M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$14.25M	USD	1 Quarter
Sales and marketing expense	`SellingAndMarketingExpense`	$13.46M	USD	1 Quarter
Sales and marketing expense	`SellingAndMarketingExpense`	$36.35M	USD	3 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$18.80M	USD	1 Quarter
Sales and marketing expense	`SellingAndMarketingExpense`	$56.05M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$8.13M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$42.54M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$23.64M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$16.44M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$207.89M	USD	3 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$123.32M	USD	3 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$45.90M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$78.33M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-17.48M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-56.41M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-24.20M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-65.56M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$958.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.93M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$4.29M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$9.87M	USD	3 Qtrs
Interest expense	`InterestExpense`	$304.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$952.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$860.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$280.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$4.59M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$275.00K	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$43.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$179.00K	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-13.29M	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-23.51M	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-47.12M	USD	3 Qtrs
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-58.99M	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$3.00K	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-1.38M	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-202.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.09M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.64M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.30M	USD	1 Quarter
Net loss	`ProfitLoss`	$-45.74M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-58.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-23.51M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	$950.00K	USD	3 Qtrs
Fair value adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	$-300.00K	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	$950.00K	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	$4.70M	USD	3 Qtrs
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.79M	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-24.46M	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-50.44M	USD	3 Qtrs
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.94M	USD	3 Qtrs
Net loss per share attributable to common stockholders, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.56	USD	3 Qtrs
Net loss per share attributable to common stockholders, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-1.94	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-4.87	USD	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	93.30M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.45M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.58M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.30M	shares	3 Qtrs

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-13.09M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.64M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.30M	USD	1 Quarter
Net loss	`ProfitLoss`	$-45.74M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-58.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-23.51M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.97M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.96M	USD	3 Qtrs
Unrealized translation gains on obligation related to royalty	`UnrealizedTranslationsGainLossOnObligationRelatedToRoyalty`	$251.00K	USD	3 Qtrs
Unrealized translation gains on obligation related to royalty	`UnrealizedTranslationsGainLossOnObligationRelatedToRoyalty`	$330.00K	USD	3 Qtrs
Non-cash stock-based compensation	`ShareBasedCompensation`	$11.88M	USD	3 Qtrs
Non-cash stock-based compensation	`ShareBasedCompensation`	$4.29M	USD	3 Qtrs
Non-cash interest expense	`NoncashInterestExpensePaid`	-	USD	3 Qtrs
Non-cash interest expense	`NoncashInterestExpensePaid`	$10.00K	USD	3 Qtrs
Amortization of discounts on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.95M	USD	3 Qtrs
Amortization of discounts on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-41.00K	USD	3 Qtrs
Benefit from income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-1.24M	USD	3 Qtrs
Benefit from income taxes	`DeferredIncomeTaxesAndTaxCredits`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-908.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.85M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-212.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$5.62M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.48M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$453.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.04M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-97.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$426.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.35M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$11.62M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$2.52M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$541.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$6.37M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-1.09M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-3.46M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-3.04M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$842.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.79M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-45.65M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$542.47M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$48.69M	USD	3 Qtrs
Maturity of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$223.06M	USD	3 Qtrs
Maturity of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$110.62M	USD	3 Qtrs
Business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.33M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.63M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.27M	USD	3 Qtrs
Purchases of intangible assets and capitalized license obligations	`PaymentsToAcquireIntangibleAssets`	$2.57M	USD	3 Qtrs
Purchases of intangible assets and capitalized license obligations	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-340.93M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$44.66M	USD	3 Qtrs
Payments made on royalty obligations	`PaymentRelatedtoSettlementofDebtandBuyoutofRoyaltyObligations`	-	USD	3 Qtrs
Payments made on royalty obligations	`PaymentRelatedtoSettlementofDebtandBuyoutofRoyaltyObligations`	$228.00K	USD	3 Qtrs
Payments made on capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$420.00K	USD	3 Qtrs
Payments made on capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$79.00K	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$9.79M	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.57M	USD	3 Qtrs
Proceeds from issuance of common stock upon the exercise of warrants	`ProceedsFromWarrantExercises`	$38.00K	USD	3 Qtrs
Proceeds from issuance of common stock upon the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$172.00K	USD	3 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$5.12M	USD	3 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	-	USD	3 Qtrs
Proceeds from follow-on offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	3 Qtrs
Proceeds from follow-on offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOrSaleOfEquity`	$350.43M	USD	3 Qtrs
Payment of offering costs related to initial public offering and follow-on offering	`PaymentsOfStockIssuanceCosts`	$811.00K	USD	3 Qtrs
Payment of offering costs related to initial public offering and follow-on offering	`PaymentsOfStockIssuanceCosts`	$221.00K	USD	3 Qtrs
Net proceeds from issuance of equity interests in redeemable noncontrolling interest	`ProceedsFromMinorityShareholders`	$41.00M	USD	3 Qtrs
Net proceeds from issuance of equity interests in redeemable noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$364.23M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$42.80M	USD	3 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-27.00K	USD	3 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$137.00K	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.64M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$41.78M	USD	3 Qtrs
Cash, cash equivalents and restricted cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.54M	USD	Point-in-time
Cash, cash equivalents and restricted cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.54M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$860.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$67.00K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$298.00K	USD	3 Qtrs
Purchases of property and equipment included in accounts payable and accrued expenses	`IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid`	$1.86M	USD	3 Qtrs
Purchases of property and equipment included in accounts payable and accrued expenses	`IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid`	$6.42M	USD	3 Qtrs
Deferred offering costs included in accounts payable and accrued expenses	`OfferingCostsIncurredbutNotyetPaid`	$4.04M	USD	3 Qtrs
Deferred offering costs included in accounts payable and accrued expenses	`OfferingCostsIncurredbutNotyetPaid`	-	USD	3 Qtrs
Initial fair value of contingent consideration at acquisition date	`BusinessCombinationContingentConsiderationLiability`	$1.06M	USD	Point-in-time
Initial fair value of contingent consideration at acquisition date	`BusinessCombinationContingentConsiderationLiability`	-	USD	Point-in-time

Stockholders Equity 60 line items

Line Item	Tag	Value	Unit	Period
Stock offering costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$723.00K	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`ReclassificationsOfTemporaryToPermanentEquity`	$300.00K	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`ReclassificationsOfTemporaryToPermanentEquity`	$-950.00K	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`ReclassificationsOfTemporaryToPermanentEquity`	$-4.70M	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`ReclassificationsOfTemporaryToPermanentEquity`	$-300.00K	USD	1 Quarter
Beginning balance	`StockholdersEquity`	$483.15M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$255.19M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$276.78M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$308.61M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$468.13M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$815.40M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$296.85M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$815.47M	USD	Point-in-time
Issuance of common stock upon follow-on offering, net of offering costs of $723	`StockIssuedDuringPeriodValueNewIssues`	$349.71M	USD	1 Quarter
Issuance of common stock upon exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2.63M	shares	3 Qtrs
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.26M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$424.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$839.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.99M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.10M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$538.00K	USD	1 Quarter
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueStockOptionsExercisedEarly`	$56.00K	USD	1 Quarter
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueStockOptionsExercisedEarly`	$13.00K	USD	1 Quarter
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueStockOptionsExercisedEarly`	$13.00K	USD	1 Quarter
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.93M	USD	1 Quarter
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$3.19M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.18M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.21M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.18M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.83M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.28M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.48M	USD	1 Quarter
Issuance of common stock upon exercise of warrants	`StockIssuedDuringPeriodValueExerciseofWarrants`	$33.00K	USD	1 Quarter
Issuance of common stock upon exercise of warrants	`StockIssuedDuringPeriodValueExerciseofWarrants`	$4.00K	USD	1 Quarter
Issuance of common stock upon exercise of warrants	`StockIssuedDuringPeriodValueExerciseofWarrants`	$2.00K	USD	1 Quarter
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$172.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$1.00K	USD	3 Qtrs
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$-235.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$161.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$1.19M	USD	3 Qtrs
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$1.01M	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$138.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$416.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$-298.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.09M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.64M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.30M	USD	1 Quarter
Net loss	`ProfitLoss`	$-45.74M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-58.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-23.51M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$483.15M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$255.19M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$276.78M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$308.61M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$468.13M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$815.40M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$296.85M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$815.47M	USD	Point-in-time

Comprehensive Income 36 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-13.09M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.64M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.30M	USD	1 Quarter
Net loss	`ProfitLoss`	$-45.74M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-58.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-23.51M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$28.00K	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-282.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.05M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$188.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-27.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$47.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-27.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$137.00K	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.00K	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-235.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$161.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.19M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.01M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$138.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$416.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-298.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-23.35M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-58.99M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-13.32M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-44.55M	USD	3 Qtrs
Comprehensive gain (loss) attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$950.00K	USD	1 Quarter
Comprehensive gain (loss) attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$950.00K	USD	3 Qtrs
Comprehensive gain (loss) attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$4.70M	USD	3 Qtrs
Comprehensive gain (loss) attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-300.00K	USD	1 Quarter
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-13.03M	USD	1 Quarter
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-59.94M	USD	3 Qtrs
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-49.25M	USD	3 Qtrs
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-24.30M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.